Literature DB >> 8781771

Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats.

S Roy1, M Lorenzi.   

Abstract

The histological lesions of diabetic micro-angiopathy have a long latency, but vascular cell function may be affected at early stages of the process. Rats with experimental galactosaemia develop a diabetic-like retinopathy in the absence of other metabolic abnormalities characteristic of diabetes mellitus; basement membrane thickening is measurable in their retinal vessels after 7 months of galactose feeding. To examine the course of biosynthetic changes relevant to the process, retinal expression of collagen IV and fibronectin were compared in rats fed a 30% galactose diet or a control diet for 5 or 9 weeks. Total retinal RNA was studied by reverse transcription-polymerase chain reaction; the fibronectin primers encompassed the alternatively spliced EIIIA exon. The levels of alpha 1 (IV) collagen and fibronectin mRNAs were measured relative to an internal standard (beta-actin mRNA). The proportion of EIIIA+ to EIIIA- fibronectin transcripts was similar in the retinas of control and galactose-fed rats, which, however, showed increased levels of both fibronectin and collagen IV mRNAs in the presence of unchanged beta-actin mRNA levels. An upward trend was detected by 5 weeks of galactose feeding; and after 9 weeks the fibronectin/actin ratio was 1.2 +/- 0.3 vs 0.8 +/- 0.2 in controls (p = 0.015) and the collagen IV/actin ratio was 1.3 +/- 0.3 vs 0.9 +/- 0.2 in controls (p = 0.04). Thus, hyperhexosaemia of a few weeks' duration is a perturbation sufficient to increase the synthesis of basement membrane components in the retina. The search for additional early biosynthetic changes should assist in reconstructing the pathogenesis of hexose-induced retinal microangiopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781771     DOI: 10.1007/bf00418547

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.

Authors:  A Das; R N Frank; N L Zhang; E Samadani
Journal:  Exp Eye Res       Date:  1990-03       Impact factor: 3.467

2.  Collagen IV mRNA expression during development of the mouse retina: an in situ hybridization study.

Authors:  V Sarthy
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

3.  Immunocytochemical localization of laminin, type IV collagen and fibronectin in rat retinal vessels.

Authors:  E Essner; W L Lin
Journal:  Exp Eye Res       Date:  1988-08       Impact factor: 3.467

Review 4.  Retinopathy in animal models of diabetes.

Authors:  R L Engerman; T S Kern
Journal:  Diabetes Metab Rev       Date:  1995-07

5.  Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells.

Authors:  E Cagliero; T Roth; S Roy; M Lorenzi
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

6.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.

Authors:  W G Robison; P F Kador; J H Kinoshita
Journal:  Science       Date:  1983-09-16       Impact factor: 47.728

8.  Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro.

Authors:  L J Mandarino; N Sundarraj; J Finlayson; H R Hassell
Journal:  Exp Eye Res       Date:  1993-11       Impact factor: 3.467

9.  Increased expression of basement membrane collagen in human diabetic retinopathy.

Authors:  S Roy; M Maiello; M Lorenzi
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Fibronectin overexpression in retinal microvessels of patients with diabetes.

Authors:  S Roy; E Cagliero; M Lorenzi
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-02       Impact factor: 4.799

  10 in total
  13 in total

1.  Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.

Authors:  Sumon Roy; Dongjoon Kim; Cristina Hernández; Rafael Simó; Sayon Roy
Journal:  Exp Eye Res       Date:  2015-08-18       Impact factor: 3.467

2.  Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.

Authors:  Dongjoon Kim; Robert P Mecham; Ngan-Ha Nguyen; Sayon Roy
Journal:  Exp Eye Res       Date:  2019-05-06       Impact factor: 3.467

3.  Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.

Authors:  Kyle Trudeau; Sumon Roy; Wen Guo; Cristina Hernández; Marta Villarroel; Rafael Simó; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

Review 4.  Diabetic retinopathy, superoxide damage and antioxidants.

Authors:  Julia M Santos; Ghulam Mohammad; Qing Zhong; Renu A Kowluru
Journal:  Curr Pharm Biotechnol       Date:  2011-03-01       Impact factor: 2.837

5.  A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Authors:  Jithan V Aukunuru; Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Randall C Clark; Uday B Kompella
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

6.  Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival: Implications for Diabetic Retinopathy.

Authors:  Dongjoon Kim; Dayeun Lee; Philip C Trackman; Sayon Roy
Journal:  Am J Pathol       Date:  2019-09-16       Impact factor: 4.307

Review 7.  Pathophysiology of diabetic retinopathy.

Authors:  Joanna M Tarr; Kirti Kaul; Mohit Chopra; Eva M Kohner; Rakesh Chibber
Journal:  ISRN Ophthalmol       Date:  2013-01-15

8.  Hyperhexosemia-Induced Retinal Vascular Pathology in a Novel Primate Model of Diabetic Retinopathy.

Authors:  Argyrios Chronopoulos; Sumon Roy; Ekaterina Beglova; Keith Mansfield; Lynn Wachtman; Sayon Roy
Journal:  Diabetes       Date:  2015-03-02       Impact factor: 9.461

Review 9.  Cellular signaling and potential new treatment targets in diabetic retinopathy.

Authors:  Zia A Khan; Subrata Chakrabarti
Journal:  Exp Diabetes Res       Date:  2007

Review 10.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.